Literature DB >> 15958520

Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.

Michael Quante1, Steffen Heeg, Alexander von Werder, Gitta Goessel, Christine Fulda, Michaela Doebele, Hiroshi Nakagawa, Roderick Beijersbergen, Hubert E Blum, Oliver G Opitz.   

Abstract

Telomerase activity is observed in approximately 90% of human cancer including esophageal squamous cell cancer. Normal somatic cells do not display telomerase activity on a regular basis. The major mechanism to regulate telomerase activity in human cells is the transcriptional control of the catalytic subunit, the human reverse transcriptase gene hTERT. However, the manner in which telomerase activity is regulated during malignant transformation and whether this regulation is influenced by single genetic alterations important in this process are not well understood. In this study we investigated the transcriptional regulation and activity of human telomerase in a cellular model representing important known genetic alterations observed in esophageal cancer. We characterized the respective cells with regard to their telomere biology and telomerase expression, transcriptional regulation using promoter--as well as electrophoretic mobility shift assay--analyses and their promoter methylation status. We could demonstrate that telomerase expression and subsequent activity are differentially regulated in the progression from normal esophageal epithelial cells to genetically defined esophageal cells harboring a specific genetic alteration frequently found in esophageal cancer and compared those changes with esophageal cancer cells. Whereas primary esophageal cells are mainly regulated by Sp1, in cells harboring a genetic alteration as cyclin D1 overexpression other transcription factors like E2F and c-myc as well as promoter methylation influence hTERT transcription. This model demonstrates that the transcriptional regulation of telomerase is influenced by a given genetic alteration important in esophageal cancer, and therefore provides new insight in telomerase regulation during carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958520     DOI: 10.1093/carcin/bgi153

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

Review 1.  Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.

Authors:  Alexander Link; Francesc Balaguer; Ajay Goel
Journal:  Biochem Pharmacol       Date:  2010-06-26       Impact factor: 5.858

2.  PinX1 inhibits telomerase activity in gastric cancer cells through Mad1/c-Myc pathway.

Authors:  Hong-bin Wang; Xing-wei Wang; Gang Zhou; Wei-qiang Wang; Yong-gang Sun; Shi-ming Yang; Dian-chun Fang
Journal:  J Gastrointest Surg       Date:  2010-06-11       Impact factor: 3.452

3.  Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.

Authors:  Joel B Berletch; Canhui Liu; William K Love; Lucy G Andrews; Santosh K Katiyar; Trygve O Tollefsbol
Journal:  J Cell Biochem       Date:  2008-02-01       Impact factor: 4.429

4.  Diazoxide-mediated growth inhibition in human lung cancer cells via downregulation of beta-catenin-mediated cyclin D1 transcription.

Authors:  Jianyong Ding; Di Ge; Weigang Guo; Chunlai Lu
Journal:  Lung       Date:  2008-12-04       Impact factor: 2.584

5.  Epigenetic targets of bioactive dietary components for cancer prevention and therapy.

Authors:  Syed M Meeran; Amiya Ahmed; Trygve O Tollefsbol
Journal:  Clin Epigenetics       Date:  2010-12-01       Impact factor: 6.551

Review 6.  Diverse regulatory manners of human telomerase reverse transcriptase.

Authors:  Meng-Meng Jie; Xing Chang; Shuo Zeng; Cheng Liu; Guo-Bin Liao; Ya-Ran Wu; Chun-Hua Liu; Chang-Jiang Hu; Shi-Ming Yang; Xin-Zhe Li
Journal:  Cell Commun Signal       Date:  2019-06-11       Impact factor: 5.712

Review 7.  Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer.

Authors:  Steffen Heeg
Journal:  Pharmgenomics Pers Med       Date:  2015-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.